Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 105Terminated 46Active not recruiting 20Recruiting 14Withdrawn 8Unknown 7Not yet recruiting 4Suspended 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Recurrence 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1

Interventions

Specimen Handling 17Biopsy 12Magnetic Resonance Spectroscopy 10Cyclophosphamide 9venetoclax 5Etoposide 4Azacitidine 4fludarabine phosphate 3fludarabine 3durvalumab 3X-Rays 3Tacrolimus 3Paclitaxel 3Interleukin-2 3Gemcitabine 3Cisplatin 3Carboplatin 3zanubrutinib 2prednylidene 2deltacortene 2aldesleukin 2Vincristine 2Taxes 2Stem Cell Transplantation 2Rituximab 2Radiotherapy, Intensity-Modulated 2Radiosurgery 2Protein Subunit Vaccines 2Prednisone 2Platinum 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Suspended × Rituximab × Clear all
NCT04850495 2026-06-04

Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma

Ohio State University Comprehensive Cancer Center

Phase 1 Suspended
38 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT06824701 2026-04-06

TARZAN

University of Utah

Phase 1 Suspended
24 enrolled
Lymphoid

Recurrence, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡